B. Collet

发表

Proteomic analysis underlines the usefulness of both primary adherent and stem-like cell lines for studying proteins involved in human glioblastoma.

J. Mosser, M. Aubry, P. Le Reste, 2014, Journal of proteomics.

Differential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach

Jean Mosser, Charles Pineau, Nathalie Guitton, 2011, Proteome Science.

Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Rα2, gp100 and TRP-2 for immunotherapy

J. Bansard, B. Drénou, V. Quillien, 2006, Journal of Neuro-Oncology.

111Indium-F(ab)'2-NCA 102 monoclonal antibody: in vitro study of a specific agent for the detection of inflammatory foci.

A. Moisan, P. Bourguet, J. Le Cloirec, 1993, Nuclear medicine and biology.

Immunoscintigraphy of human lung squamous cell carcinoma using an iodine-131 labelled monoclonal antibody (Po66).

P. Bourguet, L. Dazord, B. Collet, 1990, British Journal of Cancer.

Distribution of radiolabelled monoclonal antibody Po66 after intravenous injection into nude mice bearing human lung cancer grafts

D. Bourel, P. Bourguet, L. Dazord, 2005, Cancer Immunology, Immunotherapy.

Expression of MAGE genes in esophageal squamous-cell carcinoma.

Quillien, D. Heresbach, F. Brasseur, 1997, Anticancer research.

Purification of a Tumoral Marker Recognized by Monoclonal Antibody Po66 and Associated with Human Lung Squamous Cell Carcinoma

C. Pineau, F. Brichory, J. Le Pennec, 1996, The International journal of biological markers.

Monoclonal antibody AP-282 recognizes a marker for human polymorphonuclear granules.

B. Drénou, C. Picot, B. Collet, 1992, Hybridoma.

Injection by various routes of melanoma antigen-associated macrophages: biodistribution and clinical effects

B. Drénou, V. Quillien, A. Moisan, 2003, Cancer Immunology, Immunotherapy.

Immunologic and Clinical Effects of Injecting Mature Peptide-Loaded Dendritic Cells by Intralymphatic and Intranodal Routes in Metastatic Melanoma Patients

V. Quillien, V. Vignard, N. Labarrière, 2006, Clinical Cancer Research.

MMP7 cleavage of amino-terminal CD95 death receptor switches signaling toward non-apoptotic pathways

C. Di Primo, A. Penna, Patrick Legembre, 2022, Cell Death & Disease.

Scintigraphic detection in mice of inflammatory lesions and tumours by an indium-labelled monoclonal antibody directed against Mac-1 antigen

D. Bourel, A. Moisan, B. Collet, 2004, Cancer Immunology, Immunotherapy.

Monoclonal antibody AMH152 reacts with human monocytes in culture and with inflammatory macrophages.

R. Audran, B. Collet, L. Toujas, 1992, Research in immunology.

Production of the Non-apoptotic Metalloprotease-Cleaved CD95L and Its Cytotoxic Recombinant Counterpart Designed Ig-CD95L.

Sophie Martin, B. Collet, E. Lepvrier, 2017, Methods in molecular biology.

Influence of the culture conditions of brucella abortus on its antitumor properties

A. Ruffault, B. Collet, F. Sauvager, 2004, Cancer Immunology, Immunotherapy.

Blood clearance and organ distribution of intravenously administered polymethacrylic nanoparticles in mice.

A. Rolland, R. Le Verge, B. Collet, 1989, Journal of pharmaceutical sciences.

Antitumor properties of chemically detoxified killed Brucella abortus organisms

B. Collet, L. Toujas, C. Pilet, 1981, Cancer Immunology, Immunotherapy.

Differentiation of cytotoxic adherent cells from peroxidase positive cells after intraperitoneal injection of Brucella abortus organisms.

B. Collet, L. Toujas, A. Martín, 1983, International journal of immunopharmacology.

Effect of an anti-HLA class I monoclonal antibody on the antigenic and transcriptional expression of HLA class I genes in U937 cells.

R. Fauchet, T. Guillaudeux, B. Collet, 1992, Tissue antigens.

Fate of mouse macrophages radiolabelled with PKH-95 and injected intravenously.

A. Moisan, R. Audran, B. Collet, 1995, Nuclear medicine and biology.

Uptake and release of radiolabelled monoclonal antibody Po66 by multicellular aggregates obtained from a lung squamous carcinoma cell line.

L. Dazord, J. Guiraud, B. Collet, 1993, Anticancer research.

Overview of Cellular Immunotherapy for Patients with Glioblastoma

J. Mosser, V. Quillien, E. Vauléon, 2010, Clinical & developmental immunology.

Activation of mouse macrophages by muramyl dipeptide coupled with an anti-macrophage monoclonal antibody.

M. Monsigny, P. Midoux, A. Roche, 1992, Bioconjugate chemistry.

Characterization of the antigen identified by Po66

P. Youinou, D. Bourel, B. Collet, 2004, Cancer Immunology, Immunotherapy.

Characterization and sorting of mouse cytotoxic macrophages by their light scattering properties.

B. Genetet, B. Collet, G. Merdrignac, 1983, Cytometry.

Serum anti-p53 antibodies in patients with squamous cell carcinoma of the esophagus.

D. Heresbach, J. Decertaines, V. Quillien, 1997, International journal of oncology.

Differentiation of the P-gp and MRP1 multidrug resistance systems by mobile lipid 1H-NMR spectroscopy and phosphatidylserine externalization.

J. D. de Certaines, O. Fardel, L. Le Moyec, 2001, Anticancer research.